bosulif
pfizer europe ma eeig - bosutiniib (monohüdraadina) - leukeemia, müeloid - antineoplastic agents, protein kinase inhibitors - bosulif on näidustatud ravi täiskasvanud patsientidel, kellel on:äsja diagnoositud krooniline faas (lp) philadelphia kromosoom-positiivse kroonilise müeloidse leukeemia (ph+ cml). cp, kiirendatud etapp (ap), ja plahvatuse etapp (bp) ph+ cml eelnevalt ravitud ühe või mitme türosiinkinaasi inhibiitor(s) [tki(s)] ja kellele imatinib, nilotinib ja dasatinib ei ole asjakohane ravi valikud.
dasatinib accord
accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
dasatinib accordpharma
accord healthcare s.l.u. - dasatiniib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastilised ained - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 20mg 12tk; 20mg 56tk
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 50mg 60tk
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 70mg 56tk; 70mg 60tk
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 80mg 30tk; 80mg 10tk
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 100mg 30tk; 100mg 10tk
dasatinib sandoz õhukese polümeerikattega tablett
sandoz pharmaceuticals d.d. - dasatiniib - õhukese polümeerikattega tablett - 140mg 30tk; 140mg 10tk
dasatinib zentiva õhukese polümeerikattega tablett
zentiva k.s. - dasatiniib - õhukese polümeerikattega tablett - 50mg 60tk